| scholarly article | Q13442814 |
| P50 | author | Ellen Hatch | Q57982426 |
| P2093 | author name string | Bao Lu | |
| Steven H Sacks | |||
| Neil S Sheerin | |||
| Ziyong Tang | |||
| P2860 | cites work | Epithelial-mesenchymal transition and its implications for fibrosis | Q24302042 |
| Complement. First of two parts | Q28210663 | ||
| Complement. Second of two parts | Q28211878 | ||
| Role of complement in acute tubulointerstitial injury of rats with aminonucleoside nephrosis | Q28379067 | ||
| Complement inhibitors targeted to the proximal tubule prevent injury in experimental nephrotic syndrome and demonstrate a key role for C5b-9 | Q28573545 | ||
| Evidence that fibroblasts derive from epithelium during tissue fibrosis | Q29616581 | ||
| Role of CD8(+) cells in the progression of murine adriamycin nephropathy | Q32082443 | ||
| Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes | Q34331403 | ||
| Epithelial-to-mesenchymal transition of human proximal tubular epithelial cells: effects of rapamycin, mycophenolate, cyclosporin, azathioprine, and methylprednisolone | Q80112123 | ||
| Complement activation contributes to both glomerular and tubulointerstitial damage in adriamycin nephropathy in mice | Q80209369 | ||
| The alternative pathway of complement is activated in the glomeruli and tubulointerstitium of mice with adriamycin nephropathy | Q80375869 | ||
| TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease | Q34581113 | ||
| Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis | Q35087744 | ||
| Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis | Q35746891 | ||
| Interstitial nephritis induced by protein-overload proteinuria | Q35817159 | ||
| A relationship between proteinuria and acute tubulointerstitial disease in rats with experimental nephrotic syndrome | Q35830280 | ||
| Why is proteinuria an ominous biomarker of progressive kidney disease? | Q35918705 | ||
| Complement-mediated dysfunction of glomerular filtration barrier accelerates progressive renal injury | Q36677636 | ||
| Interstitial myofibroblasts: predictors of progression in membranous nephropathy | Q37202587 | ||
| The transcription factors AP-1 and Ets are regulators of C3a receptor expression | Q38319410 | ||
| Significance of tubulointerstitial changes in the renal cortex for the excretory function and concentration ability of the kidney: a morphometric contribution | Q39718181 | ||
| High levels of complement C3a receptor in the glomeruli in lupus nephritis | Q40138591 | ||
| Use of monoclonal antibodies to assess expression of anaphylatoxin receptors in tubular epithelial cells of human, murine and rat kidneys | Q40163511 | ||
| Transdifferentiation of cultured tubular cells induced by hypoxia | Q40590913 | ||
| The consequences for renal function of widening of the interstitium and changes in the tubular epithelium of the renal cortex and outer medulla in various renal diseases | Q41114296 | ||
| Cell lines with extended in vitro growth potential from human renal proximal tubule: characterization, response to inducers, and comparison with established cell lines | Q41125748 | ||
| Elevated urinary excretion of the C5b-9 complex in membranous nephropathy | Q41148483 | ||
| Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. | Q42461036 | ||
| Accelerated nephrotoxic nephritis is exacerbated in C1q-deficient mice | Q43612859 | ||
| BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury | Q44479221 | ||
| Blockade of CD40-CD40 ligand protects against renal injury in chronic proteinuric renal disease | Q44581630 | ||
| Renal expression of the C3a receptor and functional responses of primary human proximal tubular epithelial cells | Q45050747 | ||
| C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis | Q45116503 | ||
| Signaling through up-regulated C3a receptor is key to the development of experimental lupus nephritis | Q46610901 | ||
| Synthesis of complement protein C3 in the kidney is an important mediator of local tissue injury | Q46881209 | ||
| Myeloma light chains induce epithelial-mesenchymal transition in human renal proximal tubule epithelial cells | Q46953152 | ||
| The membrane attack complex, C5b-9, up regulates collagen gene expression in renal tubular epithelial cells. | Q47927287 | ||
| Transforming growth factor production by chemically transformed cells | Q52826927 | ||
| Complement 3 is involved in changing the phenotype of human glomerular mesangial cells. | Q53551146 | ||
| The Brush Border of Proximal Tubules of Normal Human Kidney Activates the Alternative Pathway of the Complement System In Vitroa | Q58831953 | ||
| A role for the C3a anaphylatoxin receptor in the effector phase of asthma | Q59068707 | ||
| Measurement of SC5b-9 in urine in patients with the nephrotic syndrome | Q67804910 | ||
| Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulo-interstitial changes | Q69952626 | ||
| Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study | Q71777734 | ||
| Myofibroblasts, predictors of progression of mesangial IgA nephropathy? | Q72396539 | ||
| Membrane attack complex and membrane cofactor protein are related to tubulointerstitial inflammation in various human glomerulopathies | Q73091717 | ||
| Complement membrane attack complex (C5b-9) mediates interstitial disease in experimental nephrotic syndrome | Q73131858 | ||
| C3a is made by proximal tubular HK-2 cells and activates them via the C3a receptor | Q73205085 | ||
| Complement activation products in the urine from proteinuric patients | Q73638841 | ||
| The role of complement in the pathogenesis of tubulointerstitial lesions in rat mesangial proliferative glomerulonephritis | Q73691361 | ||
| C5a is important in the tubulointerstitial component of experimental immune complex glomerulonephritis | Q77146531 | ||
| C6 mediates chronic progression of tubulointerstitial damage in rats with remnant kidneys | Q77816447 | ||
| C3a is required for the production of CXC chemokines by tubular epithelial cells after renal ishemia/reperfusion | Q79609757 | ||
| Biliary epithelial-mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis | Q80060245 | ||
| P433 | issue | 3 | |
| P921 | main subject | kidney disease | Q1054718 |
| P304 | page(s) | 593-603 | |
| P577 | publication date | 2009-01-21 | |
| P1433 | published in | Journal of the American Society of Nephrology | Q17123893 |
| P1476 | title | C3a mediates epithelial-to-mesenchymal transition in proteinuric nephropathy | |
| P478 | volume | 20 |
| Q34882286 | A complement receptor C5a antagonist regulates epithelial to mesenchymal transition and crystallin expression after lens cataract surgery in mice |
| Q90681133 | Absence of the Lectin Activation Pathway of Complement Ameliorates Proteinuria-Induced Renal Injury |
| Q42386506 | All Things Complement |
| Q38238367 | Alport syndrome: its effects on the glomerular filtration barrier and implications for future treatment |
| Q38035773 | An update on the pathomechanisms and future therapies of Alport syndrome |
| Q35083760 | Anti-complement component C5 mAb synergizes with CTLA4Ig to inhibit alloreactive T cells and prolong cardiac allograft survival in mice. |
| Q35080166 | Artemisinin analogue SM934 ameliorates the proteinuria and renal fibrosis in rat experimental membranous nephropathy |
| Q89666162 | Associations of Ficolins With Hematological Malignancies in Patients Receiving High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantations |
| Q36200905 | C3a and C5a promote renal ischemia-reperfusion injury |
| Q64076914 | C3a and suPAR drive versican V1 expression in tubular cells of focal segmental glomerulosclerosis |
| Q28545168 | C3a receptor antagonist ameliorates inflammatory and fibrotic signals in type 2 diabetic nephropathy by suppressing the activation of TGF-β/smad3 and IKBα pathway |
| Q37792654 | Cancer and the Complement Cascade |
| Q39097599 | Classical complement pathway activation in the nasal tissue of patients with chronic rhinosinusitis |
| Q45908661 | Complement 3 activates the renal renin-angiotensin system by induction of epithelial-to-mesenchymal transition of the nephrotubulus in mice. |
| Q48269323 | Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis |
| Q92335780 | Complement activation by autoantigen recognition in the growth process of benign prostatic hyperplasia |
| Q38348940 | Complement activation in progressive renal disease |
| Q38217273 | Complement as a multifaceted modulator of kidney transplant injury |
| Q40986583 | Complement in Non-Antibody-Mediated Kidney Diseases. |
| Q26827470 | Complement regulation of T cell immunity |
| Q26823956 | Complement regulation of T-cell alloimmunity |
| Q35151737 | Complement regulation of T-cell alloimmunity. |
| Q36913772 | Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis |
| Q27302883 | Control of the collective migration of enteric neural crest cells by the Complement anaphylatoxin C3a and N-cadherin |
| Q34828696 | Correlation analysis connects cancer subtypes |
| Q34365488 | Crosstalk between TGF-β1 and complement activation augments epithelial injury in pulmonary fibrosis |
| Q84372476 | Distinct roles for C3a and C5a in complement-induced tubulointerstitial injury |
| Q34386483 | Downsizing a human inflammatory protein to a small molecule with equal potency and functionality. |
| Q26995453 | Effects of complement activation on allograft injury |
| Q45025014 | Enhanced complement activation is part of the unfavourable cardiovascular risk profile in South Asians |
| Q39759058 | Epidemiology of glomerulonephritis in Northern Germany |
| Q34786452 | Failure of anti tumor-derived endothelial cell immunotherapy depends on augmentation of tumor hypoxia. |
| Q35131205 | Glomerular proteinuria: a complex interplay between unique players |
| Q53159611 | ISN Forefronts Symposium 2010 in Sylt, Germany: 'Induction and Resolution of Renal Inflammation'. |
| Q95840971 | Inflammaging and Complement System: A Link Between Acute Kidney Injury and Chronic Graft Damage |
| Q90626648 | Linking innate immunity and chronic antibody-mediated allograft rejection |
| Q39229285 | Many drugs for many targets: novel treatments for complement-mediated glomerular disease |
| Q33711255 | Molecular mechanisms of chronic kidney transplant rejection via large-scale proteogenomic analysis of tissue biopsies. |
| Q33419651 | Molecules Great and Small: The Complement System |
| Q60313364 | Myofibroblasts in macular fibrosis secondary to neovascular age-related macular degeneration - the potential sources and molecular cues for their recruitment and activation |
| Q37439735 | Nitro-oleic acid protects against adriamycin-induced nephropathy in mice |
| Q37657039 | Novel aspects of complement in kidney injury |
| Q27004486 | Obstacles in haemocompatibility testing |
| Q91614118 | Pathological significance of urinary complement activation in diabetic nephropathy: A full view from the development of the disease |
| Q30999305 | Quantitative and qualitative urinary cellular patterns correlate with progression of murine glomerulonephritis |
| Q24657528 | Renal fibrosis |
| Q33647738 | Review: Complement and its regulatory proteins in kidney diseases |
| Q39352236 | Role of complement 3 in TNF-α-induced mesenchymal transition of renal tubular epithelial cells in vitro |
| Q92097260 | Role of complement 3 in the pathogenesis of hypertension |
| Q47560276 | Screening of genes involved in epithelial-mesenchymal transition and differential expression of complement-related genes induced by PAX2 in renal tubules |
| Q38850489 | Targeting the complement cascade: novel treatments coming down the pike. |
| Q48284080 | The C3aR promotes macrophage infiltration and regulates ANCA production but does not affect glomerular injury in experimental anti-myeloperoxidase glomerulonephritis. |
| Q99711527 | The Complement C3a and C3a Receptor Pathway in Kidney Diseases |
| Q49401359 | The Complement System in Dialysis: A Forgotten Story? |
| Q36846948 | The Expression Profile of Complement Components in Podocytes |
| Q40725046 | The complement receptor C5aR1 contributes to renal damage but protects the heart in angiotensin II-induced hypertension |
| Q88129968 | The relationship between complement C3 expression and the MUC5B genotype in pulmonary fibrosis |
| Q35231345 | The role of complement in tumor growth |
| Q37275159 | The role of the complement system in acute kidney injury |
| Q26851705 | Therapeutic regulation of complement in patients with renal disease - where is the promise? |
| Q61444784 | Upregulated long noncoding RNA LOC105375913 induces tubulointerstitial fibrosis in focal segmental glomerulosclerosis |
| Q57790022 | Urinary properdin excretion is associated with intrarenal complement activation and poor renal function |
Search more.